(Reuters) - Indivior Plc said on Wednesday a U.S. court ruling had put a hold on Indian rival Dr. Reddy's Laboratories launching a generic competitor to the London-listed drugmaker's bestselling opioid addiction treatment.
Indivior said a preliminary injunction against Dr. Reddy's, in connection with Indivior's Suboxone Film, would remain in place.
(Reporting by Arathy S Nair in Bengaluru; Editing by Sai Sachin Ravikumar)
Disclaimer: No Business Standard Journalist was involved in creation of this content
